Patent · US Active

Dialysis composition comprising citrate, calcium and magnesium

US9452149B2 · kind B2 · utility

5Cited by

1References

13Claims

0Family size

Assignee

GAMBRO LUNDIA AB · SE

Inventors

Anders Nilsson · Västerås, SE
Jan Sternby · Lund, SE
Anders Wieslander · Lund, SE

Key dates

Filing date	Mar 5, 2013
Grant date	Sep 27, 2016
Priority date	—
Expiry date	Mar 5, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61M1/1654
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Dialysis fluid compositions including 0.5 to 3 mM citrate, 1 to 5 mM total calcium, and 0 to 1.5 mM total magnesium. These dialysis fluid compositions include 0.10 to 0.2 mM more total calcium per 1 mM citrate within the dialysis fluid as compared to the calcium concentration ordinarily prescribed for a non-citrate containing dialysis fluid.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.